CVE-2023-50341: Hcltech Dryice Myxalytics

High severity, CVSS 7.5. EPSS: 0.4% chance of exploitation in the next 30 days.

HCL DRYiCE MyXalytics is impacted by Improper Access Control (Obsolete web pages) vulnerability. Discovery of outdated and accessible web pages, reflects a "Missing Access Control" vulnerability, which could lead to inadvertent exposure of sensitive information and/or exposing a vulnerable endpoint.

Affected products

• Hcltech Dryice Myxalytics: version 5.9 only; version 6.0 only; version 6.1 only

Published 2024-01-03. Last modified 2026-06-17.